Key Dates

Related Announcements

RFA-CA-22-022 - Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

Issued by

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to correct the section on Key Dates in RFA-CA-22-022, Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional), by stating that "No late applications will be accepted for this Funding Opportunity Announcement."

Part 1. Overview Information, Key Dates

Currently reads:

All applications are due by 5:00 PM local time of applicant organization. 

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Should correctly read (in italics):

All applications are due by 5:00 PM local time of applicant organization. 

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

No late applications will be accepted for this Funding Opportunity Announcement.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Scientific/Research Contact(s)

Juli Klemm, Ph.D.
National Cancer Institute (NCI)
Telephone: 202-853-7889
Email: [email protected]

Peer Review Contact(s)

Referral Officer
National Cancer Institute (NCI)
Telephone: 240-276-6390
Email: [email protected]